Clinical Trials In New Hampshire

Discover hundreds of clinical trials in New Hampshire.
Search clinical trials in New Hampshire by city, condition or phase.

e.g. Respiratory Diseases

New Hampshire•Healthy volunteers: No

Filter results

Results: 336

Testing the Addition of the Chemotherapy Drug Lomustine (Gleostine®) to the Usual Treatment (Temozolomide and Radiation Therapy) for Newly Diagnosed MGMT Methylated Glioblastoma

Recruiting

Phase 3

Sponsor:

NRG Oncology

Location:

Lebanon, Little Rock, Anaheim, Antiochshow 191 more

Code:

NCT05095376

Conditions

Glioblastoma

Gliosarcoma

Eligibility Criteria

Sex: All

Age: 18 - 70

Healthy Volunteers: Not accepted

Interventions

Lomustine

Photon Beam Radiation Therapy

Quality-of-Life Assessment

Questionnaire Administration

Temozolomide

A Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986278 in Participants With Idiopathic Pulmonary Fibrosis

Recruiting

Phase 3

Sponsor:

Bristol-Myers Squibb

Location:

Birmingham, Jasper, Phoenix, La Jollashow 72 more

Code:

NCT06003426

Conditions

Idiopathic Pulmonary Fibrosis

Eligibility Criteria

Sex: All

Age: 40+

Healthy Volunteers: Not accepted

Interventions

BMS-986278

BMS-986278 Placebo

Product Surveillance Registry

Recruiting

Sponsor:

Medtronic

Location:

Lebanon, Birmingham, Huntsville, Anchorageshow 126 more

Code:

NCT01524276

Conditions

Cardiac Rhythm Disorders

Urological Disorders

Neurological Disorders

Cardiovascular Disorders

Digestive Disorders

Eligibility Criteria

Sex: All

Age: 0 - 70+

Healthy Volunteers: Not accepted

A Study of the Drugs Selumetinib Versus Carboplatin/Vincristine in Patients With Neurofibromatosis and Low-Grade Glioma

Recruiting

Phase 3

Sponsor:

National Cancer Institute (NCI)

Location:

Lebanon, Birmingham, Mesa, Phoenixshow 95 more

Code:

NCT03871257

Conditions

Low Grade Glioma

Neurofibromatosis Type 1

Visual Pathway Glioma

Eligibility Criteria

Sex: All

Age: 2 - 21

Healthy Volunteers: Not accepted

Interventions

Carboplatin

Magnetic Resonance Imaging

Quality-of-Life Assessment

Questionnaire Administration

Selumetinib Sulfate

Study of Kidney Tumors in Younger Patients

Recruiting

Sponsor:

Children's Oncology Group

Location:

Lebanon, Birmingham, Mobile, Anchorageshow 146 more

Code:

NCT00898365

Conditions

Adult Cystic Nephroma

Anaplastic Kidney Wilms Tumor

Angiolipoma

Cellular Congenital Mesoblastic Nephroma

Classic Congenital Mesoblastic Nephroma

Eligibility Criteria

Sex: All

Age: 0 - 29

Healthy Volunteers: Not accepted

Interventions

Cytology Specimen Collection Procedure

Laboratory Biomarker Analysis

e.g. Respiratory Diseases

New Hampshire•Healthy volunteers: No

Filter results

Results: 336

Testing the Addition of the Chemotherapy Drug Lomustine (Gleostine®) to the Usual Treatment (Temozolomide and Radiation Therapy) for Newly Diagnosed MGMT Methylated Glioblastoma

Recruiting

Phase 3

Sponsor:

NRG Oncology

Location:

Lebanon, Little Rock, Anaheim, Antiochshow 191 more

Code:

NCT05095376

Conditions

Glioblastoma

Gliosarcoma

Eligibility Criteria

Sex: All

Age: 18 - 70

Healthy Volunteers: Not accepted

Interventions

Lomustine

Photon Beam Radiation Therapy

Quality-of-Life Assessment

Questionnaire Administration

Temozolomide

A Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986278 in Participants With Idiopathic Pulmonary Fibrosis

Recruiting

Phase 3

Sponsor:

Bristol-Myers Squibb

Location:

Birmingham, Jasper, Phoenix, La Jollashow 72 more

Code:

NCT06003426

Conditions

Idiopathic Pulmonary Fibrosis

Eligibility Criteria

Sex: All

Age: 40+

Healthy Volunteers: Not accepted

Interventions

BMS-986278

BMS-986278 Placebo

Product Surveillance Registry

Recruiting

Sponsor:

Medtronic

Location:

Lebanon, Birmingham, Huntsville, Anchorageshow 126 more

Code:

NCT01524276

Conditions

Cardiac Rhythm Disorders

Urological Disorders

Neurological Disorders

Cardiovascular Disorders

Digestive Disorders

Eligibility Criteria

Sex: All

Age: 0 - 70+

Healthy Volunteers: Not accepted

A Study of the Drugs Selumetinib Versus Carboplatin/Vincristine in Patients With Neurofibromatosis and Low-Grade Glioma

Recruiting

Phase 3

Sponsor:

National Cancer Institute (NCI)

Location:

Lebanon, Birmingham, Mesa, Phoenixshow 95 more

Code:

NCT03871257

Conditions

Low Grade Glioma

Neurofibromatosis Type 1

Visual Pathway Glioma

Eligibility Criteria

Sex: All

Age: 2 - 21

Healthy Volunteers: Not accepted

Interventions

Carboplatin

Magnetic Resonance Imaging

Quality-of-Life Assessment

Questionnaire Administration

Selumetinib Sulfate

Study of Kidney Tumors in Younger Patients

Recruiting

Sponsor:

Children's Oncology Group

Location:

Lebanon, Birmingham, Mobile, Anchorageshow 146 more

Code:

NCT00898365

Conditions

Adult Cystic Nephroma

Anaplastic Kidney Wilms Tumor

Angiolipoma

Cellular Congenital Mesoblastic Nephroma

Classic Congenital Mesoblastic Nephroma

Eligibility Criteria

Sex: All

Age: 0 - 29

Healthy Volunteers: Not accepted

Interventions

Cytology Specimen Collection Procedure

Laboratory Biomarker Analysis